{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:33:22Z","timestamp":1791804802877,"version":"4.3.4"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cervical cancer is the fourth most common cancer and fourth leading cause of cancer death among women worldwide. In low Human Development Index settings, it ranks second. Screening and surveillance involve the cytology-based Papanicolaou (Pap) test and testing for high-risk human papillomavirus (hrHPV). The Pap test has low sensitivity to detect precursor lesions, while a single hrHPV test cannot distinguish a persistent infection from one that the immune system will naturally clear. Furthermore, among women who are hrHPV-positive and progress to high-grade cervical lesions, testing cannot identify the ~20% who would progress to cancer if not treated. Thus, reliable detection and treatment of cancers and precancers requires routine screening followed by frequent surveillance among those with past abnormal or positive results. The consequence is overtreatment, with its associated risks and complications, in screened populations and an increased risk of cancer in under-screened populations. Methods to improve cervical cancer risk assessment, particularly assays to predict regression of precursor lesions or clearance of hrHPV infection, would benefit both populations. Here we show that women who have lower risk results on follow-up testing relative to index testing have evidence of enhanced T cell clonal expansion in the index cervical cytology sample compared to women who persist with higher risk results from index to follow-up. We further show that a machine learning classifier based on the index sample T cells predicts this transition to lower risk with 95% accuracy (19\/20) by leave-one-out cross-validation. Using T cell receptor deep sequencing and machine learning, we identified a biophysicochemical motif in the complementarity-determining region 3 of T cell receptor \u03b2 chains whose presence predicts this transition. While these results must still be tested on an independent cohort in a prospective study, they suggest that this approach could improve cervical cancer screening by helping distinguish women likely to spontaneously regress from those at elevated risk of progression to cancer. The advancement of such a strategy could reduce surveillance frequency and overtreatment in screened populations and improve the delivery of screening to under-screened populations.<\/jats:p>","DOI":"10.3389\/fimmu.2021.624230","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T04:19:53Z","timestamp":1617337193000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Precancer Risk Estimates"],"prefix":"10.3389","volume":"12","author":[{"given":"Scott","family":"Christley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Ostmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Quirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Sirak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Monson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Tiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay G.","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02896","article-title":"Involvement of Human Papillomaviruses in Cervical Cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S178381","article-title":"Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus","volume":"12","author":"Toh","year":"2019","journal-title":"Infect Drug Resist"},{"key":"B5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines - A review of the first decade","volume":"146","author":"Harper","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e019206","DOI":"10.1136\/bmjopen-2017-019206","article-title":"Parents\u2019 uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies","volume":"8","author":"Newman","year":"2018","journal-title":"BMJ Open"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/2150131917742299","article-title":"The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review","volume":"8","author":"Loke","year":"2017","journal-title":"J Prim Care Community Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"Force","year":"2018","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.03.008","article-title":"Cervical cancer screening in Europe: Quality assurance and organisation of programmes","volume":"51","author":"Elfstrom","year":"2015","journal-title":"Eur J Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000326956","article-title":"Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective","volume":"55","author":"Farnsworth","year":"2011","journal-title":"Acta Cytol"},{"key":"B15","volume-title":"Cervix Cancer Screening","year":"2005"},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD008587","DOI":"10.1002\/14651858.CD008587.pub2","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"8","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djg037","article-title":"Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia","volume":"95","author":"Schlecht","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji186","article-title":"Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities","volume":"97","author":"Castle","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"B19","doi-asserted-by":"publisher","first-page":"CD008054","DOI":"10.1002\/14651858.CD008054.pub2","article-title":"Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions","volume":"3","author":"Arbyn","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00265-12","article-title":"Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds","volume":"50","author":"Trope","year":"2012","journal-title":"J Clin Microbiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28984","article-title":"Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial","volume":"136","author":"Elfstrom","year":"2015","journal-title":"Int J Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/jtgga.2016.0138","article-title":"Do clinical data and human papilloma virus genotype influence spontaneous regression in grade I cervical intraepithelial neoplasia","volume":"18","author":"Cortes-Alaguero","year":"2017","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp058171","article-title":"The promise of global cervical-cancer prevention","volume":"353","author":"Schiffman","year":"2005","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0901167","article-title":"From India to the world\u2013a better way to prevent cervical cancer","volume":"360","author":"Schiffman","year":"2009","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.1522","article-title":"Human Papillomavirus Triage of Women With Atypical Squamous Cells of Undetermined Significance-Reduction of Overtreatment Needed","volume":"3","author":"Meijer","year":"2017","journal-title":"JAMA Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.1040","article-title":"Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing","volume":"3","author":"Cuzick","year":"2017","journal-title":"JAMA Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32849","article-title":"Reducing overtreatment associated with overdiagnosis in cervical cancer screening-A model-based benefit-harm analysis for Austria","volume":"147","author":"Sroczynski","year":"2020","journal-title":"Int J Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"CD012847","DOI":"10.1002\/14651858.CD012847","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease","volume":"11","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0165276","DOI":"10.1371\/journal.pone.0165276","article-title":"Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study","volume":"12","author":"Weinmann","year":"2017","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0485-5","article-title":"Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer","volume":"18","author":"Sasagawa","year":"2012","journal-title":"J Infect Chemother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/1874357901206010241","article-title":"The immune response to papillomavirus during infection persistence and regression","volume":"6","author":"Hibma","year":"2012","journal-title":"Open Virol J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002756","article-title":"Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium","volume":"185","author":"Trimble","year":"2010","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"831907","DOI":"10.1155\/2013\/831907","article-title":"Prognostic significance of immunohistochemical phenotypes in patients treated for high-grade cervical intraepithelial neoplasia","volume":"2013","author":"Origoni","year":"2013","journal-title":"BioMed Res Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.10.7176","article-title":"IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions","volume":"179","author":"Seresini","year":"2007","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ygyno.2005.11.039","article-title":"Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix","volume":"102","author":"Monnier-Benoit","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00262-011-1092-5","article-title":"CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend","volume":"61","author":"Kim","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: a prognostic factor that should not be ignored","volume":"29","author":"Pages","year":"2010","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/bjc.2011.189","article-title":"The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis","volume":"105","author":"Gooden","year":"2011","journal-title":"Br J Cancer"},{"key":"B41","article-title":"Tumor-infiltrating memory T-lymphocytes for prognostic prediction in cancer patients: a meta-analysis","volume":"8","author":"Jia","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovic","year":"2015","journal-title":"J Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.aak9510","article-title":"Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer","volume":"356","author":"Stevanovic","year":"2017","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1457","article-title":"The Diagnostic, Prognostic, and Therapeutic Potential of Adaptive Immune Receptor Repertoire Profiling in Cancer","volume":"80","author":"Cowell","year":"2020","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12859-017-1814-6","article-title":"Statistical classifiers for diagnosing disease from immune repertoires: a case study using multiple sclerosis","volume":"18","author":"Ostmeyer","year":"2017","journal-title":"BMC Bioinf"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-2292","article-title":"Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue","volume":"79","author":"Ostmeyer","year":"2019","journal-title":"Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0225","article-title":"Going Beyond the Sequences: TCR Binding Patterns at the Service of Cancer Detection","volume":"79","author":"Zoete","year":"2019","journal-title":"Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/s12859-019-3281-8","article-title":"Immune repertoire fingerprinting by principal component analysis reveals shared features in subject groups with common exposures","volume":"20","author":"Sevy","year":"2019","journal-title":"BMC Bioinf"},{"key":"B49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13075-019-2069-6","article-title":"High-throughput sequencing of CD4(+) T cell repertoire reveals disease-specific signatures in IgG4-related disease","volume":"21","author":"Wang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0229569","DOI":"10.1371\/journal.pone.0229569","article-title":"Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma","volume":"15","author":"Ostmeyer","year":"2020","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0178167","DOI":"10.1371\/journal.pone.0178167","article-title":"T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study","volume":"13","author":"Lang Kuhs","year":"2018","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02729","article-title":"TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer","volume":"9","author":"Cui","year":"2018","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00262-009-0806-4","article-title":"Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2\/3","volume":"59","author":"Trimble","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/978-1-4612-2042-8","article-title":"Second edition of \u2018The Bethesda System for reporting cervical cytology\u2019 - atlas, website, and Bethesda interobserver reproducibility project","volume":"1","author":"Nayar","year":"2004","journal-title":"Cytojournal"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"16","author":"Darragh","year":"2012","journal-title":"J Low Genit Tract Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00976","article-title":"VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements","volume":"9","author":"Christley","year":"2018","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.3020-3027.1998","article-title":"Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method","volume":"36","author":"Gravitt","year":"1998","journal-title":"J Clin Microbiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses","volume":"38","author":"Gravitt","year":"2000","journal-title":"J Clin Microbiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1086\/521629","article-title":"The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0151","article-title":"The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States","volume":"17","author":"Giuliano","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408677102","article-title":"Solving the protein sequence metric problem","volume":"102","author":"Atchley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.patcog.2017.10.009","article-title":"Multiple instance learning: A survey of problem characteristics and applications","volume":"77","author":"Carbonneau","year":"2018","journal-title":"Pattern Recognition"},{"key":"B63","doi-asserted-by":"publisher","first-page":"214ra169","DOI":"10.1126\/scitranslmed.3007247","article-title":"Digital genomic quantification of tumor-infiltrating lymphocytes","volume":"5","author":"Robins","year":"2013","journal-title":"Sci Transl Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1038\/ncomms3680","article-title":"Using synthetic templates to design an unbiased multiplex PCR assay","volume":"4","author":"Carlson","year":"2013","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217604","article-title":"Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells","volume":"114","author":"Robins","year":"2009","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1008376","DOI":"10.1371\/journal.ppat.1008376","article-title":"Cervicovaginal microbiome and natural history of HPV in a longitudinal study","volume":"16","author":"Usyk","year":"2020","journal-title":"PloS Pathog"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1006","article-title":"The Immune Epitope Database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz874","article-title":"VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium","volume":"48","author":"Bagaev","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx286","article-title":"McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences","volume":"33","author":"Tickotsky","year":"2017","journal-title":"Bioinformatics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"984528","DOI":"10.1155\/2015\/984528","article-title":"Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: A Retrospective Monoinstitutional Cohort Study","volume":"2015","author":"Del Mistro","year":"2015","journal-title":"BioMed Res Int"},{"key":"B71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","article-title":"Sample size estimation in diagnostic test studies of biomedical informatics","volume":"48","author":"Hajian-Tilaki","year":"2014","journal-title":"J BioMed Inform"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3873","article-title":"Adaptive Immune Receptor Repertoire Community recommendations for sharing immune-repertoire sequencing data","volume":"18","author":"Rubelt","year":"2017","journal-title":"Nat Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2020.00022","article-title":"The ADC API: A Web API for the Programmatic Query of the AIRR Data Commons","volume":"3","author":"Christley","year":"2020","journal-title":"Front Big Data"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.624230\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T04:19:57Z","timestamp":1617337197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.624230\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2021.624230"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.624230","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"article-number":"624230"}}